Synovial Sarcoma, X Breakpoint 2B (SSX2B) (C-Term) Antikörper
Kurzübersicht für Synovial Sarcoma, X Breakpoint 2B (SSX2B) (C-Term) Antikörper (ABIN3187724)
Target
Alle Synovial Sarcoma, X Breakpoint 2B (SSX2B) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- SSX Polyclonal Antibody detects endogenous levels of SSX protein.
-
Produktmerkmale
- Rabbit Polyclonal to SSX.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of human SSX.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-1:2000, IHC-P 1:100-300, ELISA 1:20000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C.
-
-
- Synovial Sarcoma, X Breakpoint 2B (SSX2B)
-
Andere Bezeichnung
- SSX
-
Molekulargewicht
- 21931 kDa,21620 kDa,21697 kDa,21858 kDa,21660 kDa,21688 kDa,21591 kDa,21859 kDa,21553 kDa (different Isoforms)
-
Gen-ID
- 6756
-
UniProt
- Q16384
Target
-